Equities

Pluri Inc

Pluri Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)5.55
  • Today's Change0.18 / 3.35%
  • Shares traded25.95k
  • 1 Year change-30.63%
  • Beta1.6092
Data delayed at least 15 minutes, as of May 02 2024 14:59 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Pluri Inc., formerly known as Pluristem Therapeutics Inc., is an Israel-headquartered company engaged in the research and provision of cell-based products directed for a range of industries. The Company is focused on researching and developing cell transformation and 3D cell expansion technologies that allow mass production of cells. The products of the Company are used for the pharmaceutical industry as well as for food technology, agriculture technology, and cell-based materials. In the pharmaceutical sector, the Company's preclinical and clinical programs explore multiple therapeutic areas such as vascular disease, inflammation-related conditions, muscle injuries, and hematological disorders. In the food sector, the Firm produces cultivated meat, cultivated fish, and seafood, as well as plant-based products. In agriculture, the Company develops alternative farming methods. The Company has a portfolio of over 140 granted patents in approximately 52 countries.

  • Revenue in USD (TTM)357.00k
  • Net income in USD-24.23m
  • Incorporated2001
  • Employees123.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Iterum Therapeutics PLC0.00-38.37m26.12m14.00---------2.96-2.960.00-0.47430.00----0.00-82.44-118.12-108.84-199.23-------890,554.10----1.51------13.64---32.09--
Unity Biotechnology Inc0.00-39.86m26.19m19.00--0.9221-----2.75-2.750.001.690.00----0.00-41.95-47.21-49.03-53.51-------6,395.92----0.00---100.00--10.36---61.28--
Acasti Pharma Inc0.00-38.77m26.79m32.00--0.4142-----5.06-5.060.006.880.00-------40.18-45.71-41.30-50.84-------69,798.47---14.380.00-------332.11---45.53--
BioVie Inc0.00-43.27m27.08m18.00--2.62-----1.19-1.190.000.1880.00----0.00-125.99-456.35-184.48-1,810.88------------0.5764-------92.67------
Ayala Pharmaceuticals Inc13.00k-48.07m27.42m20.00------2,109.04-7.46-7.460.0022-2.06------650.00--------0.00---369,784.60-----2.31----------------
Pluri Inc357.00k-24.23m28.07m123.00--6.36--78.63-4.75-4.750.06980.84430.007----2,902.44-48.19-60.85-55.78-71.3728.57---6,850.42-30,867.06---34.180.7867--22.6541.8330.18---5.19--
bioAffinity Technologies Inc2.53m-7.94m28.21m75.00--4.74--11.14-0.9036-0.90360.28950.51680.2482144.956.1633,766.67-77.80---93.28--31.26---313.41--1.76--0.1983--52,660.42--2.66------
Aprea Therapeutics Inc583.24k-14.29m28.51m7.00--1.16--48.88-4.00-4.000.16134.890.0221----83,320.00-54.11-68.66-63.19-77.19-----2,449.55-42,112.84----0.00------87.32--90.61--
RenovoRx Inc0.00-10.23m28.98m8.00---------1.01-1.010.00-0.28050.00----0.00-234.38---317.07-----------------------3.47------
Spruce Biosciences Inc10.09m-47.92m29.52m29.00--0.3847--2.93-1.26-1.260.26221.860.1064----347,896.60-50.55-41.24-62.77-46.49-----474.96-1,774.39---107.650.0418-------3.77------
Brainstorm Cell Therapeutics Inc0.00-17.19m29.69m29.00---------0.4079-0.40790.00-0.08030.00----0.00-271.62-117.19---231.65--------------------29.18---45.34--
Earth Science Tech Inc5.98m330.94k29.91m8.0098.9613.8656.515.000.0010.0010.01950.00693.1611.41106.07747,970.0017.50-224.8442.70--62.2937.795.53-333.580.386-0.38990.1023--243.77-36.31-111.95------
DURECT Corp8.55m-27.62m30.01m58.00--1.98--3.51-1.12-1.120.32570.48730.16240.79273.65147,379.30-52.47-37.34-124.79-53.4479.9191.83-323.16-139.111.20-55.630.5299---55.67-10.9621.82---10.98--
Aptorum Group Ltd1.20m-13.40m30.09m18.00--1.30--25.08-3.64-3.640.32344.220.062474.8717.3666,656.11-80.15-42.74-68.67-46.937.33-2.90-1,283.55-1,477.581.32-94.530.0066---15.95--60.88---42.83--
Singular Genomics Systems Inc2.91m-94.82m30.10m255.00--0.1679--10.34-1.30-1.300.042.420.00980.21823.9411,415.69-31.96---33.80---19.17---3,257.30--9.77--0.0474--280.52---4.34------
Palatin Technologies, Inc.7.10m-30.91m30.18m34.00------4.25-2.48-2.480.5582-0.79560.31180.87173.42208,755.90-135.79-26.11-269.84-30.6895.34---435.53-126.201.09------230.53-40.8723.91--80.82--
Data as of May 02 2024. Currency figures normalised to Pluri Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.